NASHP

How States Are Leveraging Payment to Improve the Delivery of SUD Services

March 15, 2022/by Neva Kaye

As overdose fatalities increase, reaching a historic peak of over 100,000 deaths in 2020, states are continuing to invest in strategies to improve access to treatment for individuals with substance use disorder (SUD). This rise highlights the issues posed by the COVID-19 pandemic to SUD providers. Disruptions and changes in service delivery, and resulting changes in payment, have posed challenges to efforts to increase access to treatment. Policymakers in some states are starting to use the payments they make to providers and managed care plans as effective levers to increase both treatment access and service quality in their Medicaid programs. This toolkit, which is based on state interviews and documentation, examines Medicaid payment strategies that four states (Arizona, New York, Oregon, and Pennsylvania) use to improve SUD treatment for Medicaid beneficiaries.

Acknowledgements: The National Academy for State Health Policy (NASHP) would like to thank the state officials from the Arizona Health Care Cost Containment System, New York State Department of Health, New York State Office of Addiction Services and Supports, Oregon Health Authority, and Pennsylvania Department of Human Services who contributed to the brief, including reviewing a draft of the document. In addition, we thank Health Resources and Services Administration Project Officer Diba Rab and her colleagues for their feedback and guidance. Finally, the authors wish to thank Hemi Tewarson, Kitty Purington, and Jodi Manz of NASHP for their contributions to the paper. This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under co-operative agreement number UD3OA22891, National Organizations of State and Local Officials. The information, content, and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. government.

Copyright © 2019, by The National Academy for State Health Policy. All rights reserved. May not be published or otherwise distributed without explicit permission | Privacy Policy | Terms Of Use